Natural-Product Humic Acid - Laub BioChem

(3281) R. J. Laub. Synthetic soil-extract materials and
medicaments for influenza viruses based thereon. US
6,576,229 (June 10, 2003).
Respiratory Infections
(4229) A. Jankowski, B. Nienartowicz, B. Polanska, and A.
Lewandowicz-Uszynska. A randomized, double-blind
study on the efficacy of Tolpa Torf Preparation (TTP)
in the treatment of recurrent respiratory tract
infections. Arch. Immunol. Therap. Exper. 1993, 41(1),
95-97.
Rous sarcoma
(3255) V. A. Trofimov, V. P. Shipov, E. S. Pigarev, A. I. Popov,
V. N. Ivanov, and G. S. Shitikova. Method for
producing an antiviral agent. WO 2001/097,750
(December 27, 2001).
Anti-Viral Mechanisms of Drug Action
(4228) J. Zhuang and Y. Jin. Virus retention and transport as
influenced by different forms of soil organic matter. J. Environ.
Qual. 2003, 32(3), 816-823.
Immunostimulation
(3262) G. K. Joone. An in vitro and in vivo study of the
immunomodulating properties of oxihumate. Ph.D. Dissertation,
University of Pretoria, Pretoria, South Africa, 2003.
Rheumatoid Disease
Mud Baths
(4220) A. Nissenbaum, J. Rullkoetter, and Y. Yechieli. Are
the curative properties of black mud from the Dead
Sea due to the presence of bitumen (asphalt) or other
types of organic matter Environ. Geochem. Health
2002, 24(4), 327-335.
Skin Diseases
(3260) J. R. Snyman, J. Dekker, S. C. K. Malfeld, and C. E. Jansen van
Rensburg. Pilot study to evaluate the safety and therapeutic
efficacy of topical oxifulvic acid in atopic volunteers. Drug Dev.
Res. 2002, 57(1), 40-43.
(4230) E. S. Kashitskii, L. G. Barabanov, A. M. Gordeev, and A. V.
Nedashkovskii. Agent for treatment of patients with chronic
dermatosis. RU 2,187,315 (January 18, 2000).
-245-